SRL
MRNA icon

Scientech Research LLC’s Moderna MRNA Stock Holding History

Scientech Research LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
+26,826
New +$1.39M 1.52% 12
2026
Q1 		– Sell
-6,799
Closed -$201K – 638
2025
Q4 		$201K Sell
6,799
-19,112
-74% -$519K 0.13% 341
2025
Q3 		$669K Sell
25,911
-229
-0.9% -$6.39K 0.23% 174
2025
Q2 		$721K Buy
+26,140
New +$688K 0.18% 244
2025
Q1 		– Sell
-13,344
Closed -$555K – 721
2024
Q4 		$555K Buy
+13,344
New +$638K 0.16% 259
2024
Q3 		– Sell
-9,335
Closed -$1.11M – 759
2024
Q2 		$1.11M Buy
+9,335
New +$1.18M 0.23% 157
2024
Q1 		– Sell
-2,058
Closed -$205K – 515
2023
Q4 		$205K Buy
+2,058
New +$173K 0.2% 247

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Scientech Research LLC's MRNA Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Moderna (MRNA) in Q2 2026: 26,826 shares worth $1.88M. The stake represents 1.52% of the portfolio and ranks #12 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in MRNA as recently as Q4 2025.

Scientech Research LLC first reported a position in MRNA in Q4 2023 and has held it in 7 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Scientech Research LLC held 26,826 shares of Moderna worth $1.88M as of Q2 2026.
  • Moderna was a new Scientech Research LLC position in Q2 2026.
  • Moderna made up 1.52% of Scientech Research LLC's portfolio in Q2 2026, its #12 holding.
  • Scientech Research LLC first reported a position in Moderna in Q4 2023 and has held it in 7 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.